The question of what kind of particulate matter found its way into vials of Moderna’s Covid-19 vaccine deployed in Japan may have been resolved. There is as yet...
The International Society for Pharmaceutical Engineering (ISPE) announced the 2021 Facility of the Year Awards (FOYA) Category Winners—including two winners of Special...
US vaccine manufacturer Moderna has tapped Takeda as marketing partner for its Covid-19 vaccine candidate mRNA-1273f in Japan. Financial terms of the deal were not...
As rumored earlier this month, private equity group Blackstone has emerged as the winning bidder for Takeda’s consumer healthcare business. The transaction is expected to...
Japanese pharma Takeda is apparently winding down the asset-shedding drive it launched following the $59 billion acquisition of Shire. The company is currently said to be...
27.04.2020
- Takeda Pharmaceutical has agreed to sell a selection of the over-the-counter (OTC) and prescription drugs it markets in Europe to fast-growing Danish pharma Orifarm for a total of...
06.04.2020
- Japan’s Takeda Pharmaceutical is partnering with UK biotech Evox Therapeutics to develop treatments for rare diseases. Financial terms of the agreement have not been disclosed. The...
28.02.2020
- Japanese drugmaker Takeda Pharmaceutical has acquired PvP Biologics, following the conclusion of a Phase 1 proof-of-mechanism study of TAK-062 (Kuma062), an investigational...
